Literature DB >> 9088274

Prostate-specific antigen, clinical use and staging: an overview.

U H Stenman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9088274     DOI： 10.1111/j.1464-410x.1997.tb00802.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN： 0007-1331


× No keyword cloud information.
  4 in total

1.  Proteolytic activity of prostate-specific antigen (PSA) towards protein substrates and effect of peptides stimulating PSA activity.

Authors:  Johanna M Mattsson; Suvi Ravela; Can Hekim; Magnus Jonsson; Johan Malm; Ale Närvänen; Ulf-Håkan Stenman; Hannu Koistinen
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

2.  Oxibendazole inhibits prostate cancer cell growth.

Authors:  Qiaoli Chen; Yuhua Li; Xiaoyu Zhou; Runsheng Li
Journal:  Oncol Lett       Date:  2017-12-11       Impact factor: 2.967

3.  Prostate volume and prostate-specific antigen in men with Parkinson's disease are not different compared to age-matched control group: A prospective, case-controlled multicenter study.

Authors:  Yu Seob Shin; Hwang Choi; Min Woo Cheon; Seung Chol Park; Jong Kwan Park; Hyung Jin Kim; Young Beom Jeong
Journal:  Prostate Int       Date:  2015-03-19

4.  KLK-targeted Therapies for Prostate Cancer.

Authors:  Koistinen Hannu; Mattsson Johanna; Stenman Ulf-Håkan
Journal:  EJIFCC       Date:  2014-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.